🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

High Resolution Retinal Imaging

Recruitingn/aAges 7 Years - anyAllUniversity of Pennsylvania
NCT01866371 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Studying the morphology and function of the normal and diseased retina in vivo is needed for advancing the detection, diagnosis, and treatment of retinal disease. This protocol uses an adaptive optics scanning laser ophthalmoscope (AOSLO) to image the normal and diseased retina with individual cellular resolution non-invasively. The primary objective of this study is to obtain and analyze high-resolution images of the retina, in particular by imaging the cone photoreceptor mosaic, the retinal vasculature and other retinal layers. The study design will involve case-control studies, where cases are followed over time. Subjects age 7 and older may be invited to participate. The main research procedure involves retinal imaging with the AOSLO. The primary endpoint is the observation of differences in retinal images between subjects with and without retinal diseases. These changes will be quan

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Males or females age 7 years or older. * Parental/guardian permission (informed consent) and if appropriate, child assent. Child subjects age 7-17 must give assent. * Reasonable compliance with an imaging protocol as determined by the study personnel. Exclusion Criteria: * Individuals that are at risk to acute glaucoma. * Individuals that are photophobic and experience adverse psychological reactions to flashes of light. * Ocular opacities, high refractive error, and high frequency of nystagmus as determined by the study team.
💊

What it tests

  • Retinal imaging
📍

Where

1 site
University of Pennsylvania
Philadelphia, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy